Pharmaceutical care: main vectors of development and prospects perspectives

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Introduction. Provision of pharmaceutical care makes it possible to use medicines optimally and efficiently, apply professional knowledge of pharmaceutical workers effectively for the needs of the health care system thus promoting pharmaceutical industry development and increasing availability of medical care. Despite long existence of the pharmaceutical care concept in the world pharmaceutical practice and its positive contribution to public health, our country is facing difficulties of putting the concept into practice due to the lack of both a unified approach to its content and the availability of regulatory documents.

Objective: the aim of the research was to analysis and generalization of main vectors of the pharmaceutical care concept development and search for further perspectives of pharmaceutical care use within the health care system based on the international approach.

Material and methods. The study used the methods of information retrieval, generalization, formalization, logical, comparative and structural analysis. The search was conducted for the sources of information in the field of pharmaceutical care with the help of the domestic and foreign databases: Elibrary, Web of Science, Core Collection, Scopus, PubMed predominantly for the period of 2013–2014 years.

Results. Pharmaceutical care has been implemented into the pharmaceutical practice and used by many countries around the world what is due to the increase in consumption of medicines, health care costs and shortage of medical personnel, the need to reduce the burden on the medical community when treating patients with mild illnesses who seek for medical aid from specialists. Professional competences of pharmaceutical workers allow them to reveal, prevent and solve the problems related to the ways of taking medicines, their effects on the organism, and safety of patients. The pharmaceutical care concept motivates pharmaceutical workers to use their experience, knowledge, and skills in provision of medical care during medication based on new approaches and strategies. Involvement of pharmaceutical workers into the fight against COVID-19 has identified wide range of their potentials and abilities as active subjects within the healthcare system, in our country as well, which is especially important under the conditions of medical staff shortage. Pharmaceutical practice of many countries involves pharmaceutical practitioners extensively in provision of primary medical and sanitary care to sick people, they collaborate with the teams of medical professionals prescribing medicines. Despite numerous studies and scientific development, however, the health care system of our country does not show interest to promoting pharmaceutical care concept intensively or to enhancing the role of pharmaceutical workers within the public health.

Conclusion. Thus, using to apply global trends to the pharmaceutical care concept introduction into the health care system, to enhance the role of the pharmacist`s profession in the society, to expand the areas of the pharmacist`s competences and skills for the sake of medical service availability especially under the conditions of medical staff shortage, to prevent and identify all possible unfavorable effects of medicines, to develop professionally effective collaboration of patients with the medical personnel and pharmaceutists so as to achieve overall involvement and compliance of all the participants in the process of medication and getting pharmaceutical assistance thus raising the responsibility for the outcome of the patient`s therapy.

全文:

受限制的访问

作者简介

Alla Ovod

Kursk State Medical University

编辑信件的主要联系方式.
Email: aovod@mail.ru
ORCID iD: 0000-0001-9380-1138

Doctor of Pharmacy, Professor, Head of the Department of organization and management of pharmacy

俄罗斯联邦, 305041, Kursk, K. Marksa st., 3

Olga Maksimenko

Kursk State Medical University

Email: olgamaksimenko1008@yandex.ru
ORCID iD: 0009-0006-8017-9224

Assistant of the Department of organization and management of pharmacy

俄罗斯联邦, 305041, Kursk, K. Marksa st., 3

Anna Meshkova

Kursk State Medical University

Email: meshkova.nyusha@mail.ru
ORCID iD: 0009-0004-8318-9634

Candidate of the Department of organization and management of pharmacy

俄罗斯联邦, 305041, Kursk, K. Marksa st., 3

参考

  1. Hepler C.D., Strand L.M. Opportunities and Responsibilities in Pharmaceutical Care. Am. J. of Hospital Pharmacy. 1990; 47: 533–43.
  2. Дремова Н.Б., Овод А.И., Коржавых Э.А. Основы фармацевтической помощи в здравоохранении: монография. Курск: КГМУ, 2009. [Dremova N.B., Ovod A.I. Korzhavykh E.A., Fundamentals of pharmaceutical care in healthcare: a monograph. Kursk, 2009. ID: 19553850 (in Russian)].
  3. Овод А.И., Муковнина М.Д. Популяционная фармацевтическая помощь больным с урогенитальными инфекциями. Фармация. 2013; 7: 22–6. [Ovod A.I, Mukovnina M.D. Population pharmaceutical care for patients with urogenital infections. Pharmacy. 2013; 7: 22–6. ID: 38061085 (In Russ.)].
  4. Дрёмова Н.Б., Овод А.И., Коржавых Э.А., Литвинова Т.М. Фармацевтическая помощь: термин и понятие. Фармация. 2005; 2: 37–45. Dremova N.B., Ovod A.I., Korzhavykh E.A., Litvinova T.M. Pharmaceutical care: term and concept. Pharmacy. 2005; 2: 37–45. ID: 14307208 (In Russ.)].
  5. Allemann S.S., van Mil J.W.F., Botermann L., Berger K., Griese N., Hersberger K.E. Pharmaceutical Care: the PCNE definition 2013. Int. J. Clin. Pharm. 2014; 36 (3): 544–55. doi: 10.1007/s11096-014-9933-x
  6. Alves da Costa F., Henman M., Hughes C., Leufkens H., Babar Z., McElnay J. Schulz M. Impact of a global leader on pharmaceutical practice and policy around the world. J. of Pharm Policy and Pract. 2020; 13: 51. doi: 10.1186/s40545-020-00253-z
  7. Galt K.A. The Need to Define “Care” in Pharmaceutical Care: An Examination Across Research, Practice and Education. Am. J. Pharm. Educ. 2000; 64: 223–33.
  8. Hill P., Pharmaceutical care R.I.P?, Int J. Pharm Pract. 2012; 20 (1): 2–3. doi: 10.1111/j.2042-7174.2011.00184.x
  9. van Mil J.W., Fernandez-Llimos F. What is 'pharmaceutical care' in 2013? Int J. Clin Pharm. 2013; 35 (1): 1–2. doi: 10.1007/s11096-012-9728-x
  10. Овод А.И. Формирование системы качества фармацевтического образования. Карельский научный журнал. 2017; 6 (3): 50–3. [Ovod A.I. Formation of the quality system of pharmaceutical education. Karelian scientific J. 2017; 6 (3): 50–3. ID: 30453029 (In Russ.)].
  11. Gyllensten, H., Fuller J.M. & Östbring M.J. Commentary: how person-centred is pharmaceutical care? Int. J. Clin. Pharm. 2022; 44: 270–5. doi: 10.1007/s11096-021-01332-0
  12. Urick B.Y., Meggs E.V. Towards a Greater Professional Standing: Evolution of Pharmacy Practice and Education, 1920-2020. Pharmacy (Basel). 2019; 20; 7 (3): 98. doi: 10.3390/pharmacy7030098
  13. Ramalho de Oliveira D., Brummel A.R., Miller D.B. Medication therapy management: 10 years of experience in a large integrated health care system. J. Manag Care Pharm. 2010; 16 (3): 185–95. doi: 10.18553/jmcp.2010.16.3.185
  14. Latif A. Community pharmacy Medicines Use Review: current challenges. Integr Pharm Res Pract. 2018; 7: 83–92. doi: 10.2147/IPRP.S148765
  15. Madden M., Mills T., Atkin K., Stewart D., McCambridge J. Early implementation of the structured medication review in England: a qualitative study. Br. J. Gen Pract. 2022; 72 (722): e641–8. doi: 10.3399/BJGP.2022.0014
  16. Griese-Mammen N., Hersberger K.E., Messerli M., Leikola S., Horvat N., van Mil J.W.F., Kos M. PCNE definition of medication review: reaching agreement. Int. J. Clin. Pharm. 2018; 40 (5): 1199–208. doi: 10.1007/s11096-018-0696-7
  17. Patti M., Renfro C.P., Posey R., Wu G., Turner K., Ferreri S.P. Systematic review of medication synchronization in community pharmacy practice. Res Social Adm Pharm. 2019; 15 (11): 1281–8. doi: 10.1016/j.sapharm.2018.11.008
  18. Hughes T.D., Cutrell S., Minshew L.M., Brown P., Ferreri S.P. An exploration of barriers, facilitators, and practical solutions for adopting medication synchronization into community pharmacies: A qualitative analysis. Explor Res Clin Soc Pharm. 2022; 5: 100111. doi: 10.1016/j.rcsop.2022.100111
  19. Cheng A., Hughes T.D., Chen H.H., Ozawa S., Ferreri S.P. Beyond refill alignment: Evaluating the impact of appointment-based model. Res Social Adm Pharm. 2022; 18 (10): 3751–7. doi: 10.1016/j.sapharm.2022.05.004
  20. Walpola R.L., Issakhany D., Gisev N., Hopkins R.E. The accessibility of pharmacist prescribing and impacts on medicines access: A systematic review. Res Social Adm Pharm. 2024; 20 (5): 475–86. doi: 10.1016/j.sapharm.2024.01.006
  21. Alshehri A.A., Hindi A.M.K., Cheema E., Sayeed Haque M., Jalal Z., Yahyouche A. Integration of pharmacist independent prescribers into general practice: a mixed-methods study of pharmacists’ andAls patients’ views. J. Pharm. Policy Pract. 2023; 16 (1): 10. doi: 10.1186/s40545-023-00520-9
  22. Tonna A.P., Stewart D., West B., McCaig D. Pharmacist prescribing in the UK – a literature review of current practice and research. J. Clin. Pharm Ther. 2007; 32 (6): 545–56. doi: 10.1111/j.1365-2710.2007.00867.x
  23. Jebara T., Cunningham S., MacLure K., Awaisu A., Pallivalapila A., Stewart D. Stakeholders' views and experiences of pharmacist prescribing: a systematic review. Br. J. Clin Pharmacol. 2018; 84 (9): 1883–905. doi: 10.1111/bcp.13624
  24. Graham-Clarke E., Rushton A., Noblet T., Marriott J. Non-medical prescribing in the United Kingdom National Health Service: A systematic policy review. PloS One. 2019; 14 (7): e0214630. doi: 10.1371/journal.pone.0214630
  25. Hindi A.M.K., Schafheutle E.I., Jacobs S. Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients', pharmacists' and GPs' experiences and expectations. BMC Fam Pract. 2019; 20 (1): 26. DOI. 10.1186/s12875-019-0912-0
  26. Karampatakis G.D., Patel N., Stretch G., Ryan K. Integration and impact of pharmacists in general practice internationally: A rapid review. J. Health Serv Res Policy. 2024; 29 (1): 56–67. DOI. 10.1177/13558196231179831
  27. Hazen, A. C., Sloeserwij, V. M., Zwart, D. L., de Bont, A. A., Bouvy, M. L., de Gier, J. J., de Wit, N. J., & Leendertse, A. J. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT). BMC Fam Pract. 2015; 16: 76. doi: 10.1186/s12875-015-0296-8
  28. Fujita K., Halvorsen K.H., Sato N., Jazbar J., Modamio P., Waltering I., Wulf I.D. Pharmaceutical Care Network Europe definition of quality indicators for pharmaceutical care: a systematic literature review and international consensus development. Int. J. Clin. Pharm. 2024; 46 (1): 70–9. doi: 10.1007/s11096-023-01631-8
  29. Овод А.И. Уровень благополучия пациентов как индикатор качества фармацевтической помощи. Статья в сборнике трудов конференции «Состояние и перспективы фармацевтической информатики» мат. материалы круглого стола, посвященного 80-летию д. фарм. наук, проф. Л.В. Мошковой. Москва: из-во: ООО «Маркер», 2018; 56–9. [Ovod A.I. Patient well-being as an indicator of pharmaceutical care quality. In the conference proceedings «State and Prospects of Pharmaceutical Informati»" materials of the round table dedicated to the 80th anniversary of doctor of pharmaceutical sciences, professor L.V. Moshkova. Moscow: publisher: OOO "Marker", 2018; 56–9. ID: 32744672 (In Russ.)].
  30. MacCara M.E. Combatting Spanish influenza: Focus on pharmacists, pharmacies and drugs. Can Pharm J. (Ott). 2020; 153 (6): 335–42. doi: 10.1177/1715163520960178
  31. Novak H., Tadić I., Falamić S., Ortner Hadžiabdić M. Pharmacists' role, work practices, and safety measures against COVID-19: A comparative study. J. Am. Pharm Assoc (2003). 2021; 61 (4): 398–407. doi: 10.1016/j.japh.2021.03.006
  32. Cabas P., Di Bella S., Giuffrè M., Rizzo M., Trombetta C., Luzzati R., Antonello R. M., et al. Community pharmacists' exposure to COVID-19. Res Social Adm Pharm. 2021; 17 (1): 1882–7. doi: 10.1016/j.sapharm.2020.05.020
  33. Zheng S.Q., Yang L., Zhou P.X., Li H.B., Liu F., Zhao R.S. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Res Social Adm Pharm. 2021; 17 (1): 1819–24. doi: 10.1016/j.sapharm.2020.03.012
  34. Safnuk C., Ackman M.L., Schindel T.J., Watson K.E. The COVID conversations: A content analysis of Canadian pharmacy organizations' communication of pharmacists' roles and services during the COVID-19 pandemic. Can Pharm J. (Ott). 2022; 156 (1): 22–31. doi: 10.1177/17151635221139195
  35. Kambayashi D., Manabe T., Hirohara M. Adaptations in the role of pharmacists under the conditions of the COVID-19 pandemic: a systematic review and meta-analysis. BMC Health Serv Res. 2023; 23 (1): 72. doi: 10.1186/s12913-023-09071-w
  36. Bahlol M., Dewey R.S. Pandemic preparedness of community pharmacies for COVID-19. Res Social Adm Pharm. 2021; 17 (1): 1888–96. doi: 10.1016/j.sapharm.2020.05.009
  37. Henman M.C., Ravera S., Lery F.X. Council of Europe Resolution on the Implementation of Pharmaceutical Care-A Step Forward in Enhancing the Appropriate Use of Medicines and Patient-Centred Care. Healthcare (Basel). 2024; 12 (2): 232. doi: 10.3390/healthcare12020232
  38. May U., Bauer C., Schneider-Ziebe A., Giulini-Limbach C. Self-Medication in Europe: Economic and Social Impact on Individuals and Society. Gesundh ökon Qual manag. 2023; 28: 298–310. doi: 10.1055/a-2089-5142
  39. Коберник О. Национальная фармпалата намерена запустить курс по фармконсультированию. Фармацевтический вестник. 07.03.2023. [дата обращения 24.11.2024]. Доступно на: https://pharmvestnik.ru/content/articles/Nacionalnaya-farmpalata-namerena-zapustit-kurs-po-farmkonsultirovaniu.html [Kobernik O. The National Pharmaceutical Chamber intends to launch a course on pharmaceutical consulting. Pharmaceutical Bulletin [Accessed 24.11.2024]. Fvailable at https://pharmvestnik.ru/content/articles/Nacionalnaya-farmpalata-namerena-zapustit-kurs-po-farmkonsultirovaniu.html]
  40. Panfilova H., Nemchenko A., Korzh I., Zaytzeva Y., Bogdan N., Tsurikova O., Simonian L. Scientific Measurement of The Current Role of Pharmacist in the Paradigm of Pharmaceutical Care Development. Research J. Pharm. and Tech. 2019; 12 (2): 817–26. doi: 10.5958/0974-360X.2019.00142.2
  41. Панфілова Г.Л. Фармацевтична допомога як історична, нормативно-правова та соціально-економічна категорія в системі охорони здоров’я і фармацевтичному забезпеченні населення. Актуальні питання фармацевтичної і медичної науки та практики. 2014; 2 (15): 89–97. [Panfilova G.L. Pharmaceutical care as a historical, regulatory and socio-economic category in the health care system and pharmaceutical provision of the population. Current issues in pharmaceutical and medical science and practice. 2014; 2 (15): 89–97 (In Ukr.)].
  42. Унгурян Л.М., Громовик Б.П., Горілик А.В. Термінологічна сутність фармацевтичної допомоги. Одеський медичний журнал. 2012; 2 (130): 15–9. [Unguryan L.M., Gromovyk B.P., Horilyk A.V. Terminological essence of pharmaceutical care. Odessa Medical J. 2012; 2 (130): 15–9 (In Ukr.)].
  43. Майорова У.В., Козярский И.С., Годовальников Г.В. Фармацевтическая помощь: история, современное состояние и перспективы развития (литературный обзор). Рецепт: международный научно-практический журнал для фармацевтов и врачей. 2015; 1: 16–35. [Mayorova U.V., Kozyarsky I.S., Godovalnikov G.V. Pharmaceutical care: history, current state and development prospects (literature review). Recipe: international scientific and practical journal for pharmacists and doctors. 2015; 1: 16–35 (In Russ.)].
  44. Кабакова Т.И., Умирова А.А., Коржавых Э.А. Выявление и анализ векторов развития современных исследований по фармацевтической помощи. Евразийское научное объединение. 2019; 4–3 (50): 175–81. Kabakova T.I., Umirova A.A., Korzhavykh E.A. Identification and analysis of development vectors of modern research on pharmaceutical care. Eurasian Scientific Association. 2019; 4–3 (50): 175–81. ID: 38061085 (In Russ.)].

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2025